PEREGRINE CAPITAL MANAGEMENT LLC

Position in ALKS — Alkermes plc.

CIK 764529 MINNEAPOLIS, MN

Back to ALKS Full portfolio

Position in ALKS

as of Mar 31, 2026 · filed Apr 23, 2026 Compact

Position Value

$8,628,087

+$1,511,850 QoQ

Shares Held

244,007

-4.1% QoQ

Ownership

0.146%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 36.79976394119841.ToString("F0")% Shared 0.ToString("F0")% None 63.20023605880159.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PEREGRINE CAPITAL MANAGEMENT LLC holds $20,545,410 across 3 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (42.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	181,360	$8,732,484
2	ALKS	Alkermes plc. This page	244,007	$8,628,087
3	COLL	Collegium Pharmaceutical, Inc	96,306	$3,184,839

All Filings in ALKS

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,628,087	244,007	-4.1%	Shares	Sole	2026-04-23
2025-12-31	$7,116,237	254,333	-1.3%	Shares	Sole	2026-01-28
2025-09-30	$7,733,850	257,795	-2.6%	Shares	Sole	2025-10-23
2025-06-30	$7,570,778	264,620	—	Shares	Sole	2025-08-01
No filing history on record for this holder in this stock.